# Measurement of NK Cell Activity in Whole Blood in Subjects Being Screened for Colorectal Cancer Using Colonoscopy

> **NCT02291198** · NA · COMPLETED · sponsor: **ATGen Canada Inc** · enrollment: 1081 (actual)

## Conditions studied

- Natural Killer Cell Cytokine Production

## Interventions

- **DEVICE:** NK Vue: NK cell activity in stimulated whole blood

## Key facts

- **NCT ID:** NCT02291198
- **Lead sponsor:** ATGen Canada Inc
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10
- **Primary completion:** 2016-01
- **Final completion:** 2017-03
- **Target enrollment:** 1081 (ACTUAL)
- **Last updated:** 2017-08-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02291198

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02291198, "Measurement of NK Cell Activity in Whole Blood in Subjects Being Screened for Colorectal Cancer Using Colonoscopy". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT02291198. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*